These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28765245)

  • 21. Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus.
    Bartlett SJ; Hewlett S; Bingham CO; Woodworth TG; Alten R; Pohl C; Choy EH; Sanderson T; Boonen A; Bykerk V; Leong AL; Strand V; Furst DE; Christensen R;
    Ann Rheum Dis; 2012 Nov; 71(11):1855-60. PubMed ID: 22772326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials.
    Orbai AM; de Wit M; Mease P; Shea JA; Gossec L; Leung YY; Tillett W; Elmamoun M; Callis Duffin K; Campbell W; Christensen R; Coates L; Dures E; Eder L; FitzGerald O; Gladman D; Goel N; Grieb SD; Hewlett S; Hoejgaard P; Kalyoncu U; Lindsay C; McHugh N; Shea B; Steinkoenig I; Strand V; Ogdie A
    Ann Rheum Dis; 2017 Apr; 76(4):673-680. PubMed ID: 27613807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ASAS-OMERACT core domain set for axial spondyloarthritis.
    Navarro-Compán V; Boel A; Boonen A; Mease P; Landewé R; Kiltz U; Dougados M; Baraliakos X; Bautista-Molano W; Carlier H; Chiowchanwisawakit P; Dagfinrud H; de Peyrecave N; El-Zorkany B; Fallon L; Gaffney K; Garrido-Cumbrera M; Gensler LS; Haroon N; Kwan YH; Machado PM; Maksymowych WP; Poddubnyy D; Protopopov M; Ramiro S; Shea B; Song IH; van Weely S; van der Heijde D
    Semin Arthritis Rheum; 2021 Dec; 51(6):1342-1349. PubMed ID: 34489113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The OMERACT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica.
    Mackie SL; Twohig H; Neill LM; Harrison E; Shea B; Black RJ; Kermani TA; Merkel PA; Mallen CD; Buttgereit F; Mukhtyar C; Simon LS; Hill CL;
    J Rheumatol; 2017 Oct; 44(10):1515-1521. PubMed ID: 28765246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient Endorsement of the Outcome Measures in Rheumatology (OMERACT) Total Joint Replacement (TJR) clinical trial draft core domain set.
    Singh JA; Dowsey M; Choong PF
    BMC Musculoskelet Disord; 2017 Mar; 18(1):111. PubMed ID: 28298194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018.
    Aydin SZ; Robson JC; Sreih AG; Hill C; Alibaz-Oner F; Mackie S; Beard S; Gul A; Hatemi G; Kermani TA; Mahr A; Meara A; Milman N; Shea B; Tómasson G; Tugwell P; Direskeneli H; Merkel PA
    J Rheumatol; 2019 Sep; 46(9):1198-1201. PubMed ID: 30877212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.
    Hatemi G; Meara A; Ozguler Y; Direskeneli H; Mahr A; Easley E; Gurcan M; Davis T; Gul A; Yazici Y; Zottenberg K; Esatoglu SN; Erer B; Kamali S; Yazici H; Cronholm PF; Merkel PA
    J Rheumatol; 2017 Nov; 44(11):1750-1753. PubMed ID: 28365574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies.
    Miller FW; Rider LG; Chung YL; Cooper R; Danko K; Farewell V; Lundberg I; Morrison C; Oakley L; Oakley I; Pilkington C; Vencovsky J; Vincent K; Scott DL; Isenberg DA;
    Rheumatology (Oxford); 2001 Nov; 40(11):1262-73. PubMed ID: 11709610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development.
    Humphrey-Murto S; Crew R; Shea B; Bartlett SJ; March L; Tugwell P; Maxwell LJ; Beaton D; Grosskleg S; de Wit M
    J Rheumatol; 2019 Aug; 46(8):1041-1046. PubMed ID: 30770512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The OMERACT Core Domain Set for Clinical Trials of Shoulder Disorders.
    Ramiro S; Page MJ; Whittle SL; Huang H; Verhagen AP; Beaton DE; Richards P; Voshaar M; Shea B; van der Windt DA; Kopkow C; Lenza M; Jain NB; Richards B; Hill C; Gill TK; Koes B; Foster NE; Conaghan PG; Smith T; Malliaras P; Roe Y; Gagnier JJ; Buchbinder R
    J Rheumatol; 2019 Aug; 46(8):969-975. PubMed ID: 30709947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set.
    Benavent D; Carmona L; Lopez-Olivo MA; Hill CL; Westrich-Robertson T; Goel N; Strand V; Shea B; Grosskleg S; Leong A; Hofstetter C; Bingham C; Meyer D; Constien D; Berthelsen DB; Schultz G; de Groot I; Weiner J; Mather K; de Wit M; Böhm P; Cembalo SM; Tugwell P; Bruera S; Suarez-Almazor ME
    Semin Arthritis Rheum; 2024 Feb; 64():152343. PubMed ID: 38118370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
    Fertitta L; Bergqvist C; Sarin KY; Plotkin SR; Moertel C; Petersen AK; Cannon A; Berman Y; Pichard DC; Röhl C; Lessing A; Brizion B; Peiffer B; Ravaud P; Tran VT; Armand ML; Moryousef S; Ferkal S; Jannic A; Ezzedine K; Wolkenstein P;
    Br J Dermatol; 2024 Jan; 190(2):216-225. PubMed ID: 37877514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies.
    Rider LG
    Rheum Dis Clin North Am; 2002 Nov; 28(4):935-77. PubMed ID: 12506779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Core Domains for Clinical Research in Acute Respiratory Failure Survivors: An International Modified Delphi Consensus Study.
    Turnbull AE; Sepulveda KA; Dinglas VD; Chessare CM; Bingham CO; Needham DM
    Crit Care Med; 2017 Jun; 45(6):1001-1010. PubMed ID: 28375853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Core Rehabilitation Outcome Set for Single-Sided Deafness (CROSSSD) study: International consensus on outcome measures for trials of interventions for adults with single-sided deafness.
    Katiri R; Hall DA; Hoare DJ; Fackrell K; Horobin A; Hogan N; Buggy N; Van de Heyning PH; Firszt JB; Bruce IA; Kitterick PT;
    Trials; 2022 Sep; 23(1):764. PubMed ID: 36076299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.
    Orbai AM; de Wit M; Mease PJ; Callis Duffin K; Elmamoun M; Tillett W; Campbell W; FitzGerald O; Gladman DD; Goel N; Gossec L; Hoejgaard P; Leung YY; Lindsay C; Strand V; van der Heijde DM; Shea B; Christensen R; Coates L; Eder L; McHugh N; Kalyoncu U; Steinkoenig I; Ogdie A
    J Rheumatol; 2017 Oct; 44(10):1522-1528. PubMed ID: 28148697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.
    Chiarotto A; Terwee CB; Deyo RA; Boers M; Lin CW; Buchbinder R; Corbin TP; Costa LO; Foster NE; Grotle M; Koes BW; Kovacs FM; Maher CG; Pearson AM; Peul WC; Schoene ML; Turk DC; van Tulder MW; Ostelo RW
    Trials; 2014 Dec; 15():511. PubMed ID: 25540987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases.
    Lyne SA; Yip K; Vasiliou VS; Katz DA; Richards P; Tieu J; Black RJ; Bridgewater S; Palmowski A; Beaton D; Maxwell LJ; Robson JC; Mackie SL; Goodman SM; Hill CL
    Semin Arthritis Rheum; 2024 Feb; 64():152338. PubMed ID: 38134623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocol.
    Chapman LS; Redmond AC; Flurey CA; Richards P; Smith TO; Arnold JB; Beaton D; Conaghan PG; Golightly YM; Hannan MT; Hofstetter C; Maxwell LJ; Menz HB; Shea B; Tugwell P; Helliwell P; Siddle HJ
    Trials; 2023 Jan; 24(1):65. PubMed ID: 36709309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.